Aimin Zhou

Dr. Aimin Zhou


Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2016 in Cell
Verified
Journal Article
Closed access
QWQiao-Chu Wang
Qiao-Chu Wang
QZQiaoxia Zheng
Qiaoxia Zheng
HTHaiyan Tan
Haiyan Tan
BZBing Zhang
Bing Zhang
XLXiaoling Li
Xiaoling Li
TTTie-Shan Tang
Tie-Shan Tang

3 September 2008 in Cancer Chemotherapy and Pharmacology
Verified
Journal Article
Closed access
PDF file
HLHongli Liu
Hongli Liu
SLShu-Ling Liang
Shu-Ling Liang
SKSheetal Kumar
Sheetal Kumar
CWCrystal M. Weyman
Crystal M. Weyman
WLWendy Liu
Wendy Liu
AZAimin Zhou
Aimin Zhou

1 June 2014 in Analytical Biochemistry
Verified
Journal Article
Open access
QHQianyang Huang
Qianyang Huang
XZXiang Zhou
Xiang Zhou
DLDanting Liu
Danting Liu
BXBaozhong Xin
Baozhong Xin
KCKaren Cechner
Karen Cechner
AZAimin Zhou
Aimin Zhou
Gangliosides are a family of glycosphingolipids characterized by mono- or polysialic acid-containing oligosaccharides linked through 1,3- and 1,4-β glycosidic bonds with subtle differences in structure that are abundantly present in the central nervous systems of many living organisms. Their cellular surface expression and physiological malfunction are believed to be pathologically implicated in considerable neurological disorders, including Alzheimer and Parkinson diseases. Recently, studies have tentatively elucidated that mental retardation or physical stagnation deteriorates as the physiological profile of gangliosides becomes progressively and distinctively abnormal during the development of these typical neurodegenerative syndromes. In this work, a reverse-phase liquid chromatography/tandem mass spectrometry (LC/MS/MS) assay using standard addition calibration for determination of GM2, GM3, GD2, and GD3 in human plasma has been developed and validated. The analytes and internal standard were extracted from human plasma using a simple protein precipitation procedure. Then the samples were analyzed by reverse-phase ultra-performance liquid chromatography (UPLC)/MS/MS interfaced to mass spectrometry with electrospray ionization using a multiple reaction monitoring mode to obtain superior sensitivity and specificity. This assay was validated for extraction recovery, calibration linearity, precision, and accuracy. Our quick and sensitive method can be applied to monitor ganglioside levels in plasma from normal people and neurodegenerative patients.

1 July 2006 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
SLShu-Ling Liang
Shu-Ling Liang
HLHongli Liu
Hongli Liu
AZAimin Zhou
Aimin Zhou
Statins, inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase, have been used successfully in the treatment of hypercholesterolemia for more than a decade. Statins also exhibit overall clinical benefits on cardiovascular diseases independent of their effects on lowering serum cholesterol levels. These beneficial effects of statin therapy are believed to be due, at least in part, to the anti-inflammatory and immunomodulatory roles of statins. Statin treatment reduces the levels of inflammatory markers, decreases the activation and recruitment of immune cells, and delays the progression of atherosclerosis, a chronic inflammatory disease. However, little is known about the direct impact of statins on immune cells, particularly on macrophages. We report that lovastatin, a member of the statin family, effectively induces apoptosis in macrophages. Further investigation of the molecular mechanism has revealed that Rac1 and Cdc42, the small GTPase family members, may play an important role in lovastatin-induced macrophage apoptosis. Moreover, the activation of the JNK pathway may contribute to this event. Our findings provide a better understanding of the molecular basis underlying the anti-inflammatory clinical benefits of statin therapy in cardiovascular diseases.

1 January 2018 in Food Chemistry
Verified
Journal Article
Closed access
YZYanqing Zhang
Yanqing Zhang
DLDanting Liu
Danting Liu
LFLeilei Fang
Leilei Fang
XZXiaotong Zhao
Xiaotong Zhao
AZAimin Zhou
Aimin Zhou
JXJunbo Xie
Junbo Xie

24 October 2007 in Steroids
Verified
Journal Article
Open access
JCJianguo Cui
Jianguo Cui
LHLiliang Huang
Liliang Huang
LFLei Fan
Lei Fan
AZAimin Zhou
Aimin Zhou
Using β-sitosterol as a starting material, (6E)-hydroximino-24-ethylcholest-4-en-3-one (1), a natural steroidal oxime from Cinachyrella alloclada and C. apion, was synthesized in four steps with a high overall yield. First, β-sitosterol (5a) is transformed into the corresponding 24-ethylcholest-4-en-3,6-dione (6a) via oxidation with pyridinium chlorochromate (PCC). Selective reduction of 6a by NaBH4 in the presence of CoCl2 gives 24-ethylcholest- 4-en-3β-ol-6-one (7a). The reaction of 7a with hydroxylamine hydrochloride offers the oxime 8a and the oxidation of 8a by Jones reagent gives the target steroid 1. (6E)-Hydroximinocholest-4-en-3-one (2) and (6E)-hydroximino-24-ethylcholest-4,22-dien-3-one (4) were synthesized by a similar method. The cytotoxicity of the synthesized compounds against sk-Hep-1 (human liver carcinoma cell line), H-292 (human lung carcinoma cell line), PC-3 (human prostate carcinoma cell line) and Hey-1B (human ovarian carcinoma cell line) cells were investigated. The presence of a cholesterol-type side chain appears to be necessary for the biological activity.